Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Phenoxybenzamine hydrochloride may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for Phenoxybenzamine 10mg capsules belong to a group of medicines known as alpha blockers. These interfere with messages sent through nerves to control blood pressure. Phenoxybenzamine 10mg capsules are used to treat high blood pressure caused by a tumour of the adrenal glands called phaeochromocytoma. There are two adrenal glands, one on top of each kidney. In phaeochromocytoma, certain substances are released from the adrenal glands into the bloodstream in large quantities, causing high blood pressure. Your medicine is normally used when other alternative treatments are not appropriate.
e Phenoxybenzamine 10mg capsules Do not take Phenoxybenzamine 10mg capsules:
Phenoxybenzamine 10mg capsules Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. It is important to take your medicine at the right time. The capsules should be swallowed with a glass of water. Adults will normally begin with a dose of 1 capsule a day. Elderly patients may require a lower dose. Use in children Phenoxybenzamine 10mg capsules are not usually used in children, but when needed, the dose is calculated according to the child's weight. Your doctor may change your dose depending on the effect of this treatment, or may give you another medicine to take as well. Once you have started to take this medicine, your doctor will see you at regular intervals to monitor the effect and will tell you how long you need to take the capsules for. If you take more Phenoxybenzamine 10mg capsules than you should: If you take more capsules than you should, contact your doctor or nearest hospital immediately. Take any remaining capsules or this leaflet with you so the medical staff know exactly what you have taken. If you forget to take your Phenoxybenzamine 10mg capsules:
If you forget to take a dose, take the next capsule as soon as you remember, and then go on as before. It is very important, however, in order for your medicine to work, that doses are not forgotten. Do not take double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. These may include:
Phenoxybenzamine 10mg capsules Keep this medicine out of the sight and reach of children. Do not use Phenoxybenzamine 10mg capsules if the pack is damaged. Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month. Store in the original package in order to protect from light and moisture. If for any reason, you have any medicine left after your treatment, return it to your pharmacist. Remember: This medicine is for you. Only a doctor can prescribe it for you. Never give this medicine to someone else; it could harm them, even if their symptoms seem the same as yours.
What Phenoxybenzamine 10mg capsules Contain: The active substance is Phenoxybenzamine hydrochloride and each capsule contains 10mg of this substance. The other ingredients are gelatin, lactose, talc, titanium dioxide (E171), indigotin (E132), erythrosine (E127), and edible grey ink.
What Phenoxybenzamine 10mg capsules look like and contents of the pack: Phenoxybenzamine 10mg Capsules are size no. three hard gelatin capsule with opaque body and a clear red cap, both printed with 'P10' in grey. The capsules are filled with a white powder. They are usually supplied in blister packs of 30 capsules in a carton. Marketing Authorisation Holder: Mercury Pharmaceuticals Ltd, Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom Manufacturer: Dales Pharmaceuticals Ltd., Snaygill Industrial Estate, Keighley Road, Skipton, North Yorkshire, BD23 2RW Alternate Manufacturer: Central Pharma (Contract packing) Limited, Caxton Road, Bedford , MK41 0XZ, UK This leaflet was last revised in September 2023. 101944/LF/4
Phenoxybenzamine 10mg Capsules comes as capsule containing 10mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Phenoxybenzamine 10mg Capsules is phenoxybenzamine hydrochloride.
This leaflet reproduces the patient information leaflet approved for Phenoxybenzamine 10mg Capsules, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Hypertensive episodes associated with Phaeochromocytoma.
Posology
Adults: The usual starting dose is 10 mg daily. This may be increased by 10 mg daily until control of hypertensive episodes is achieved, or postural hypotension occurs. Usually the dosage required is 1-2 mg/kg body weight daily in two doses. Concomitant beta-adrenergic blockade may be necessary to control tachycardia and arrythmias notably when tumours are secreting an appreciable amount of adrenaline as well as noradrenaline.
Elderly: Use with caution: 10mg daily dose should be sufficient (see Contra-Indications and Cautions below).
Paediatric population: There is little experience in children but, doses of 1 to 2 mg/kg daily have been used successfully.
Method of Administration
Oral
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Do not use in patients who have had a cerebrovascular accident; or in the recovery period (usually 3-4 weeks) after acute myocardial infarction.
Use with great caution in patients in whom a fall in blood pressure and/or tachycardia may be undesirable, such as the elderly or those with severe heart disease, congestive heart failure, cerebrovascular disease or renal damage. The mode of action should be borne in mind, if used concurrently with α-sympatho-mimetics or myocardial depressants.
Phenoxybenzamine is carcinogenic in the rat and has shown mutagenic activity in the bacterial Ames test and mouse lymphoma assay. It should only be used after very careful consideration of the risks, in patients in which alternative treatment is inappropriate.
Excipients
Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose galactose malabsorption should not take this medicine.
See under Special Precautions and Warnings.
Pregnancy
There is little evidence of safety of Dibenyline in pregnancy and it should not be used in pregnancy unless essential.
Breast-feeding
No data available
Fertility
No data available
None known.
Side effects are generally mild and transient but may include the following adverse reactions:
Not known (cannot be estimated from the available data)
System organ class
Frequency
Adverse reactions
Nervous system disorders
Not known
dizziness
Eye disorders
Not known
miosis
Cardiac disorders
Not known
compensatory tachycardia
Vascular disorders
Not known
postural hypotension
Respiratory, thoracic and mediastinal disorders
Not known
nasal congestion
Gastrointestinal disorders
Not known
gastro-intestinal upset
Reproductive system and breast disorders
Not known
inhibition of ejaculation
General disorders and administration site conditions
Not known
lassitude
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store
Symptoms
The main effect of overdosage is profound hypotension, which may last several hours, tachycardia and collapse.
Management
Treatment consists of the induction of vomiting and/or gastric lavage together with appropriate symptomatic and supportive measures.
Treat hypotension with plasma expanders and the 'head down' position.
Noradrenaline is of little value when α-adrenergic receptors are blocked.
Adrenaline should not be used since stimulation of β-adrenergic receptors will further increase blood pressure.
Ask anything about Phenoxybenzamine 10mg Capsules. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.